2016
DOI: 10.2144/000114417
|View full text |Cite
|
Sign up to set email alerts
|

Generation of a New Gateway-Compatible Inducible Lentiviral Vector Platform Allowing Easy Derivation of Co-Transduced Cells

Abstract: In contrast to most common gene delivery techniques, lentiviral vectors allow targeting of almost any mammalian cell type, even non-dividing cells, and they stably integrate in the genome. Therefore, these vectors are a very powerful tool for biomedical research. Here we report the generation of a versatile new set of 22 lentiviral vectors with broad applicability in multiple research areas. In contrast to previous systems, our platform provides a choice between constitutive and/or conditional expression and s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 22 publications
0
9
0
Order By: Relevance
“…The sequence was cloned into pENTR3C using the CloneEZ PCR Cloning Kit (GenScript, Piscataway, NJ, USA), and substitution of the Asparagine residues into Glutamine residues was achieved by QuikChange® Site-Directed Mutagenesis Kit (Agilent, Santa Clara, US). Sequences were then transferred into pcDNA3, and custom-made doxycyline-inducible pDG2(blast)-rtTA3-FLAG lentiviral destination vectors 46 using the LR Gateway recombination system (Life Technologies, Carlsbad, CA, USA). Transient overexpression of mTRAIL-R mutants in Trail-R − / − MEFs was done by transfection of pcDNA3 plasmids using JetPRIME® transfection reagent (Polyplus-transfection® SA, Illkirch, France), following the manufacturer’s recommendations.…”
Section: Methodsmentioning
confidence: 99%
“…The sequence was cloned into pENTR3C using the CloneEZ PCR Cloning Kit (GenScript, Piscataway, NJ, USA), and substitution of the Asparagine residues into Glutamine residues was achieved by QuikChange® Site-Directed Mutagenesis Kit (Agilent, Santa Clara, US). Sequences were then transferred into pcDNA3, and custom-made doxycyline-inducible pDG2(blast)-rtTA3-FLAG lentiviral destination vectors 46 using the LR Gateway recombination system (Life Technologies, Carlsbad, CA, USA). Transient overexpression of mTRAIL-R mutants in Trail-R − / − MEFs was done by transfection of pcDNA3 plasmids using JetPRIME® transfection reagent (Polyplus-transfection® SA, Illkirch, France), following the manufacturer’s recommendations.…”
Section: Methodsmentioning
confidence: 99%
“…Since multiple different GFP variants are used to generate reporter RNA viruses, we sequenced four plasmids that encode other GFP variants ( Supplementary Figure S2 ) 23 24 . A drop in coverage at ‘CCNGCC’ or the shorter ‘CNGCC’ motif can also be observed in some of the sequences encoding these GFP variants 23 24 . Although the ‘CCNGCC’ motif is absent in the Aequorea victoria GFP coding sequence, the shorter ‘CNGCC’ motif occurs two times in this sequence (positions 820 to 824 and 975 to 979, plasmid numbering).…”
Section: Resultsmentioning
confidence: 99%
“…The sequence of NS1(1-73)Dmd-GFP-NEP and the introduced C1398T or/and C1401T mutations were confirmed by Sanger sequencing on a capillary sequencer (Applied Biosystems 3730XL DNA Analyzer). Plasmids pBluAGFP 24 , pEF6-turboGFP-MCS, pLVX-EF1a-IRES-ZsGreen1 (Clontech-BD Biosciences, Palo Alto, United States) and pDG2-hRIPK4-WT-EGFP-puro 23 were kindly provided by the BCCM/LMBP Plasmid Collection, Dr. Jens Staal and Giel Tanghe from our Department.…”
Section: Methodsmentioning
confidence: 99%
“…When using a double antibiotic approach, the mechanism of action of both antibiotics should not interfere with the interaction of DNA or RNA processes that may inhibit CRISPR/Cas9 activity. Both antibiotics must also be compatible and not show any signs of drug-drug interaction – a condition that is met by the combination of puromycin and blasticidin used in this study 1517 .…”
Section: Discussionmentioning
confidence: 99%